NCT01537666 - Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

HealthyCystic Fibrosis

Interventions

DRUG

AeroVanc

Vancomycin hydrochloride dry powder for inhalation

DRUG

IV vancomycin hydrochloride

Vancomycin hydrochloride solution for intravenous administration

Trial Locations (2)

Mater Adult Hospital, Brisbane

Linear Clinical Research Ltd., Perth